These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2872255)

  • 1. Use of implantable intraperitoneal diffusion chambers to study Bordetella pertussis pathogenesis: growth and toxin production in vivo.
    Coleman KD; Wetterlow LH
    J Infect Dis; 1986 Jul; 154(1):33-9. PubMed ID: 2872255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
    Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
    Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of cell mass and pertussis toxin by Bordetella pertussis.
    Licari P; Siber GR; Swartz R
    J Biotechnol; 1991 Sep; 20(2):117-29. PubMed ID: 1367364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor].
    Siundiukova RA; Basnak'ian IA; Stukalova NV; Aleksakhina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):14-7. PubMed ID: 10876840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice.
    Hellwig SM; Hazenbos WL; van de Winkel JG; Mooi FR
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):203-7. PubMed ID: 10575131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.
    Tuomanen E; Weiss A; Rich R; Zak F; Zak O
    Dev Biol Stand; 1985; 61():197-204. PubMed ID: 2872105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the
    Wong TY; Hall JM; Nowak ES; Boehm DT; Gonyar LA; Hewlett EL; Eby JC; Barbier M; Damron FH
    mSphere; 2019 Apr; 4(2):. PubMed ID: 30996109
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
    Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
    Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin domains in the toxin of Bordetella pertussis: selectin mimicry linked to microbial pathogenesis.
    Sandros J; Rozdzinski E; Zheng J; Cowburn D; Tuomanen E
    Glycoconj J; 1994 Dec; 11(6):501-6. PubMed ID: 7535138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heptakis (2,6-0-dimethyl)beta-cyclodextrin on cell growth and the production of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis.
    Suzuki Y; Imaizumi A; Ginnaga A; Sato H; Sato Y
    Dev Biol Stand; 1985; 61():89-92. PubMed ID: 2872134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the usefulness of Bordetella pertussis toxins for serodiagnosis of whooping cough].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 1998; 50(1-2):89-95. PubMed ID: 9857618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET.
    Veal-Carr WL; Stibitz S
    Mol Microbiol; 2005 Feb; 55(3):788-98. PubMed ID: 15661004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.
    Zealey GR; Loosmore SM; Yacoob RK; Cockle SA; Herbert AB; Miller LD; Mackay NJ; Klein MH
    Appl Environ Microbiol; 1992 Jan; 58(1):208-14. PubMed ID: 1539974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved pertussis toxin production by Bordetella pertussis through adjusting the growth medium's ionic composition.
    Frohlich BT; De Bernardez Clark ER; Siber GR; Swartz RW
    J Biotechnol; 1995 May; 39(3):205-19. PubMed ID: 7766402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice.
    Andreasen C; Powell DA; Carbonetti NH
    PLoS One; 2009 Sep; 4(9):e7079. PubMed ID: 19759900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of a pertussis toxin expression locus to isogenic bvg-positive and bvg-negative strains of Bordetella bronchiseptica using an in vivo technique.
    Smith AM; Walker MJ
    Microb Pathog; 1996 May; 20(5):263-73. PubMed ID: 8861392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
    Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
    Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of pertussis toxin to the pathogenesis of pertussis disease.
    Carbonetti NH
    Pathog Dis; 2015 Nov; 73(8):ftv073. PubMed ID: 26394801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.